1. Home
  2. |Insights
  3. |Crowdsourcing Patent Examination with the Patent Prosecution Highway

Crowdsourcing Patent Examination with the Patent Prosecution Highway

What You Need to Know

  • Key takeaway #1

    The PPH can be a useful tool for streamlining global prosecution of corresponding patent applications—which in turn can reduce costs and increase the chances of successful prosecution.

Client Alert | 1 min read | 05.15.23

The Patent Prosecution Highway (PPH) is a work-share arrangement between the patent offices of different countries. It allows for participating patent offices to share—and thus benefit from—work already performed by other participating patent offices.

In short, when a claim (or claims) of a patent application is allowed in a first patent office, a PPH request may be made to fast-track the examination of a corresponding application in a second patent office based on that allowance. So, for example, when a U.S. patent application is allowed, that allowance can be used to fast-track examination in corresponding foreign applications—or vice versa.

For U.S. applicants, the USPTO also requires that: (1) the claims of the U.S. application correspond in scope to the allowed claims of the foreign application, and (2) substantive examination of the U.S. application has not yet begun. Other countries’ requirements may differ.

Successfully utilizing the PPH can significantly reduce the time it takes for the second patent office to conduct its examination—and it is intended to do just that. While additional benefits may vary from country to country, applications examined under the PPH also generally have higher rates of allowance and suffer less from duplicative examination.

These benefits can streamline global prosecution and reduce overall costs for applicants, particularly in view of the ever growing number of countries participating in PPH programs. Presently, the USPTO has PPH agreements with patent offices of the Europe Union, United Kingdom, China, Japan, Taiwan, Mexico, Israel and several other countries and regions.

For additional information on the PPH, including country specific requirements and PPH strategies for your patent portfolio, please contact your trusted partners at Crowell & Moring.

Contacts

Insights

Client Alert | 6 min read | 04.29.26

CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)

On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies....

View All Insights